<DOC>
	<DOCNO>NCT01771198</DOCNO>
	<brief_summary>The purpose study investigate clinical efficacy oral treatment statin , SIMVASTATIN 40mg , target population patient severe chronic rhinosinusitis resistant surgery follow conventional medical surgical treatment .</brief_summary>
	<brief_title>Efficacy Study SIMVASTATIN Treat Chronic Rhinosinusitis After Failure Optimal Treatment</brief_title>
	<detailed_description>Visit Day 0 ( Screening visit ) : Once consent form sign participant identify eligible , blood test detection potential biological contraindication statin do day call Day 0 . It include complete blood count , liver function test ( AST , ALT , GGT , bilirubin , ALP ) , serum CPK serum electrolytes renal function ( CREAT , urea ) . For woman capable child , serum pregnancy test do . The final inclusion subject confirm biological result obtain validated . The patient evaluate Dr. Desrosiers accord clinical endoscopic criterion . The participant complete two questionnaire : one questionnaire question assess quality life ( SNOT-22 ) , another questionnaire nasal sinus symptom . The subject must comply observation period 30 day he/she pursue wash salt water . Visit Day 30 : Thirty day screen visit , subject normal result blood test , definitely include continue clinical trial . A clinical endoscopic sinus exam , serum pregnancy test perform administration study drug . Bacterial culture sinus use swab , brush sinus mucosa local anesthesia , also perform . Brushing sinus collect RNA present epithelial cell inflammatory nasal mucosa identification marker inflammation IL6 , IL8 , IL10 , TNF . In addition , participant must complete questionnaire nasal sinus symptom SNOT-22 questionnaire . The study medication consist take one tablet 40mg SIMVASTATIN day 30 day . This visit see begin treatment ( Day 30 ) . The subject also continue irrigation sinus saline 30 day next visit . Visit Day 60 : This follow-up visit take place 4 week begin treatment . A clinical endoscopic sinus exam , blood collection assess renal hepatic function , bacterial sinus culture , brush sinus mucosa perform . The subject must complete questionnaire nasal sinus symptom SNOT-22 questionnaire . The participant continue irrigation sinus saline 30 day next visit . Visit Day 90 : This follow-up visit take place 8 week begin treatment . A clinical endoscopic sinus exam do , participant must complete questionnaire nasal sinus symptom SNOT-22 questionnaire . Statistical analysis : Each participant his/her control . At Day 0 , Day 30 , Day 60 Day 90 , clinical endoscopic data analyze use test Brapkar qualitative match observation generalization McNemar test number category great 2 . For gene ( IL6 , IL8 , IL10 , TNF ) , deltaCt value analysis quantitative PCR ( Polymerase Chain Reaction ) compare treatment SIMVASTATIN use test pair sample : parametric test ( test ) non-parametric test ( Wilcoxon Signed-Rank Test ) .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Men woman age 18 65 year . Chronic rhinosinusitis without nasal polyposis require functional endoscopic surgery type bilateral total ethmoidectomy old six month Failure ( clinical endoscopic score &gt; 1 scale 3 ) conventional treatment surgery follow local treatment corticosteroid saline irrigation ) Cystic Fibrosis Primary immunodeficiency document acquire Diabetes Taking anticoagulant bleed disorder Taking oral cortisone within 30 day prior inclusion Taking antibiotic within 30 day prior inclusion Sinus nasal surgery past six month Contraindication statin ( pregnancy lactating ; people consume high quantity alcohol ( 3 drinks/day ) , liver disease , severe renal failure , myopathy , hypersensitivity statin , abnormally elevated transaminase coagulation )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Chronic rhinosinusitis</keyword>
	<keyword>Refractory treatment</keyword>
	<keyword>SIMVASTATIN</keyword>
</DOC>